Emerging Infectious Disease ISSN: 1080-6059

Resistance, Remission, and Qualitative Differences in HIV Chemotherapy

Denise E. Kirschner*

and G.F. Webb

Author affiliations: *University of Michigan Medical School, Ann Arbor, Michigan, USA; and †Vanderbilt University, Nashville, Tennessee, USA

Main Article

Figure 4

Four treatment simulations having a common viral set-point of disease progression. The treatment starting values are as in Figure 2. For all four simulations, the treatment parameters are c1=2.0, c2=2.0, c3=.05, the resistance mutation parameter is q=10 -8, and the threshold value is V0=2.0. Remission is achieved for the two lowest viral starting values, but the other two develop resistance. The viral exponential decay rates are -1.4, -.93, -.51, and -.26, which are inversely correlated to the v

Figure 4. Four treatment simulations having a common viral set-point of disease progression. The treatment starting values are as in Figure 2. For all four simulations, the treatment parameters are c₁=2.0, c₂=2.0, c₃=.05, the resistance mutation parameter is q=10 ^-8, and the threshold value is V₀=2.0. Remission is achieved for the two lowest viral starting values, but the other two develop resistance. The viral exponential decay rates are -1.4, -.93, -.51, and -.26, which are inversely correlated to the viral starting values (an indication of rapid suppression of virus in the external lymphoid compartment).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.